ID
16587
Description
A Study of Weekly Taxotere and Xeloda in Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00214864
Link
https://clinicaltrials.gov/show/NCT00214864
Keywords
Versions (1)
- 7/25/16 7/25/16 -
Uploaded on
July 25, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Metastatic Breast Cancer NCT00214864
Eligibility Metastatic Breast Cancer NCT00214864
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
patients with brain metastasis, adequately treated
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0220650
- UMLS CUI [1,2]
- C0332154
Description
received any anti-cancer investigational agent
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0920425
- UMLS CUI [1,2]
- C0013230
Description
previously treated with docetaxel(taxotere)or capecitabine (xeloda)
Data type
boolean
Alias
- UMLS CUI [1,1]
- C2114510
- UMLS CUI [1,2]
- C0796483
Description
GIT function, dysphagia, malabsorption
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0516983
- UMLS CUI [1,2]
- C0011168
- UMLS CUI [1,3]
- C0024523
Description
renal impairment
Data type
boolean
Alias
- UMLS CUI [1]
- C0151746
Similar models
Eligibility Metastatic Breast Cancer NCT00214864
- StudyEvent: Eligibility
C0332154 (UMLS CUI [1,2])
C0013230 (UMLS CUI [1,2])
C0796483 (UMLS CUI [1,2])
C0011168 (UMLS CUI [1,2])
C0024523 (UMLS CUI [1,3])